February 14, 2018 / 7:32 AM / 2 months ago

BRIEF-Natco Pharma Says Co's Mekaguda Facility Undergoing Routine U.S. FDA Inspection

Reuters Staff

1 Min Read

Feb 14 (Reuters) - Natco Pharma Ltd:

* NATCO PHARMA CLARIFIES ON NEWS ITEM ON US FDA INSPECTION AT CO’S MEKAGUDA FACILITY IN TELANGANA

* CO'S MANUFACTURING FACILITIES UNDERGO AUDITS FROM REGULATORY AUTHORITIES ON A REGULAR BASIS; INSPECTION IS NOT A MATERIAL EVENT‍ Source text - bit.ly/2EozLQZ Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.